Hostname: page-component-6d856f89d9-5pczc Total loading time: 0 Render date: 2024-07-16T07:17:55.742Z Has data issue: false hasContentIssue false

Implications of immunity and inflammation in schizophrenia and related psychotic disorders

Published online by Cambridge University Press:  23 March 2020

D. Mota
Affiliation:
Centro Hospitalar de Vila Nova de Gaia/Espinho, Psychiatry, Porto, Portugal
A. Coutinho
Affiliation:
Centro Hospitalar de Vila Nova de Gaia/Espinho, Psychiatry, Porto, Portugal
M. Santos
Affiliation:
Centro Hospitalar de Vila Nova de Gaia/Espinho, Psychiatry, Porto, Portugal
G. Lapa
Affiliation:
Centro Hospitalar de Vila Nova de Gaia/Espinho, Psychiatry, Porto, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Intricate interactions between the immune system and the brain might have important etiological and therapeutic implications for neuropsychiatric brain disorders. A probable association between schizophrenia and the immune system was postulated over a century ago, and is supported by epidemiological and genetic studies pointing to links with infection and inflammation.

Objective

To describe some important areas of research regarding immune response in schizophrenia and related psychotic disorders and discuss potential mechanisms and therapeutic implications of these findings.

Aims

Associations between immune response, inflammation and schizophrenia and related psychotic disorders are reviewed.

Methods

A literature review of the theme is surveyed. Several articles were search on MEDLINE with the keywords: schizophrenia, psychosis, inflammation, immunity, infection.

Results

Schizophrenia is a multifactorial disease. It is associated with multiple genetic loci that confer risk, in addition to developmental and postnatal risk factors. Antipsychotic-naive first-episode psychosis and acute psychotic relapse seems to be associated with increased serum concentrations of interleukin 6 and other proinflammatory cytokines, which are normalized after remission of symptoms with antipsychotic treatment.

Conclusions

Inflammation and immune dysfunction might contribute to cognitive, negative, and positive symptoms in schizophrenia. Identification of specific inflammatory pathways for neuropsychiatric symptoms would provide novel targets for therapeutic intervention.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV1178
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.